253 related articles for article (PubMed ID: 33128998)
1. Oxidative stress modulates rearrangement of endoplasmic reticulum-mitochondria contacts and calcium dysregulation in a Friedreich's ataxia model.
Rodríguez LR; Calap-Quintana P; Lapeña-Luzón T; Pallardó FV; Schneuwly S; Navarro JA; Gonzalez-Cabo P
Redox Biol; 2020 Oct; 37():101762. PubMed ID: 33128998
[TBL] [Abstract][Full Text] [Related]
2. Mitofusin-Dependent ER Stress Triggers Glial Dysfunction and Nervous System Degeneration in a
Edenharter O; Schneuwly S; Navarro JA
Front Mol Neurosci; 2018; 11():38. PubMed ID: 29563863
[TBL] [Abstract][Full Text] [Related]
3. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
[TBL] [Abstract][Full Text] [Related]
4. Gene editing improves endoplasmic reticulum-mitochondrial contacts and unfolded protein response in Friedreich's ataxia iPSC-derived neurons.
Mishra P; Sivakumar A; Johnson A; Pernaci C; Warden AS; El-Hachem LR; Hansen E; Badell-Grau RA; Khare V; Ramirez G; Gillette S; Solis AB; Guo P; Coufal N; Cherqui S
Front Pharmacol; 2024; 15():1323491. PubMed ID: 38420191
[TBL] [Abstract][Full Text] [Related]
5. Altered lipid metabolism in a Drosophila model of Friedreich's ataxia.
Navarro JA; Ohmann E; Sanchez D; Botella JA; Liebisch G; Moltó MD; Ganfornina MD; Schmitz G; Schneuwly S
Hum Mol Genet; 2010 Jul; 19(14):2828-40. PubMed ID: 20460268
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
7. Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia.
Soriano S; Llorens JV; Blanco-Sobero L; Gutiérrez L; Calap-Quintana P; Morales MP; Moltó MD; Martínez-Sebastián MJ
Gene; 2013 Jun; 521(2):274-81. PubMed ID: 23542074
[TBL] [Abstract][Full Text] [Related]
8. Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.
Khdour OM; Bandyopadhyay I; Chowdhury SR; Visavadiya NP; Hecht SM
Bioorg Med Chem; 2018 Jul; 26(12):3359-3369. PubMed ID: 29773347
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia.
Anderson PR; Kirby K; Orr WC; Hilliker AJ; Phillips JP
Proc Natl Acad Sci U S A; 2008 Jan; 105(2):611-6. PubMed ID: 18184803
[TBL] [Abstract][Full Text] [Related]
10. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
[TBL] [Abstract][Full Text] [Related]
11. Friedreich's ataxia: past, present and future.
Marmolino D
Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666
[TBL] [Abstract][Full Text] [Related]
12. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
[TBL] [Abstract][Full Text] [Related]
13. Metal Homeostasis Regulators Suppress FRDA Phenotypes in a Drosophila Model of the Disease.
Soriano S; Calap-Quintana P; Llorens JV; Al-Ramahi I; Gutiérrez L; Martínez-Sebastián MJ; Botas J; Moltó MD
PLoS One; 2016; 11(7):e0159209. PubMed ID: 27433942
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction in friedreich's ataxia.
Lodi R; Taylor DJ; Schapira AH
Biol Signals Recept; 2001; 10(3-4):263-70. PubMed ID: 11351132
[TBL] [Abstract][Full Text] [Related]
15. Changes in mitochondrial glutathione levels and protein thiol oxidation in ∆yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia.
Bulteau AL; Planamente S; Jornea L; Dur A; Lesuisse E; Camadro JM; Auchère F
Biochim Biophys Acta; 2012 Feb; 1822(2):212-25. PubMed ID: 22200491
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches for the treatment of Friedreich's ataxia.
Strawser CJ; Schadt KA; Lynch DR
Expert Rev Neurother; 2014 Aug; 14(8):949-57. PubMed ID: 25034024
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia.
Cotticelli MG; Xia S; Lin D; Lee T; Terrab L; Wipf P; Huryn DM; Wilson RB
J Pharmacol Exp Ther; 2019 Apr; 369(1):47-54. PubMed ID: 30635474
[TBL] [Abstract][Full Text] [Related]
18. Friedreich's ataxia.
Alper G; Narayanan V
Pediatr Neurol; 2003 May; 28(5):335-41. PubMed ID: 12878293
[TBL] [Abstract][Full Text] [Related]
19. Effect of Mitochondrial and Cytosolic FXN Isoform Expression on Mitochondrial Dynamics and Metabolism.
Agrò M; Díaz-Nido J
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158039
[TBL] [Abstract][Full Text] [Related]
20. Friedreich's ataxia: from disease mechanisms to therapeutic interventions.
Lodi R; Tonon C; Calabrese V; Schapira AH
Antioxid Redox Signal; 2006; 8(3-4):438-43. PubMed ID: 16677089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
